Compare ACAD & BANF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ACAD | BANF |
|---|---|---|
| Founded | 1993 | 1984 |
| Country | United States | United States |
| Employees | N/A | 2135 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 3.9B |
| IPO Year | 2000 | N/A |
| Metric | ACAD | BANF |
|---|---|---|
| Price | $21.69 | $113.54 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 22 | 2 |
| Target Price | $30.55 | ★ $124.00 |
| AVG Volume (30 Days) | ★ 1.7M | 126.4K |
| Earning Date | 05-06-2026 | 04-17-2026 |
| Dividend Yield | N/A | ★ 1.70% |
| EPS Growth | ★ 69.12 | N/A |
| EPS | ★ 2.30 | N/A |
| Revenue | ★ $726,437,000.00 | N/A |
| Revenue This Year | $18.90 | $6.10 |
| Revenue Next Year | $11.62 | $3.92 |
| P/E Ratio | ★ $9.81 | $16.38 |
| Revenue Growth | ★ 40.45 | N/A |
| 52 Week Low | $14.08 | $101.22 |
| 52 Week High | $28.35 | $138.15 |
| Indicator | ACAD | BANF |
|---|---|---|
| Relative Strength Index (RSI) | 46.16 | 59.69 |
| Support Level | $21.51 | $107.26 |
| Resistance Level | $22.03 | $115.58 |
| Average True Range (ATR) | 0.72 | 2.81 |
| MACD | 0.19 | 1.00 |
| Stochastic Oscillator | 51.38 | 71.60 |
Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has two core franchises in neuroscience and neuro-rare diseases. The neuroscience franchise is anchored by its commercial product NUPLAZID (pimavanserin), which is used for the treatment of hallucinations and delusions associated with Parkinson's Disease Psychosis (PDP). The neuro-rare disease franchise is anchored by the commercial product DAYBUE, which is used for the treatment of Rett syndrome. In addition, the company has various product candidates under development in different stages, including ACP-204, ACP-101, ACP-211, ACP-711, ACP-2591, etc.
BancFirst Corp is engaged in providing banking services. The company's business unit includes BancFirst metropolitan banks, BancFirst community banks, Pegasus Bank, Worthington, other financial services and executive, operations and support. BancFirst metropolitan banks, BancFirst community banks, Pegasus and Worthington offer traditional banking products such as commercial and retail lending and a full line of deposit accounts. Other financial services are specialty product business units including guaranteed small business lending, residential mortgage lending, trust services, securities brokerage, electronic banking, and insurance.